March 2014 – content
Life Science
Wafergen buys NGS library preparation business
Analytical Instruments in the new Thermo Fisher Scientific
Acquisition to make Fluidigm “single-cell technology powerhouse”
GE HLS and TFS deal not completed yet
Maverix raises funds for NGS informatics platform
Agilent enters into detector agreement
OriGene to develop antibodies for ISB
CIL enters into marketing agreement with CRO
Illumina claims sequencing milestone
General Laboratory
FEI buys rock imaging and analysis specialist
Horiba acquires fluorescence spectroscopy assets
Agilent names spin-off company
Spinnovation moves operations
Can an OEM deal re-invigorate BCI’s DLS offering?
Andor gives in to OI’s advances
Richardson Gratings publishes handbook and signs distributor
XRF specialist bought by OI
SiliCycle buys reactor product line
VWR continues regional expansion
Process & hand-held instrumentation
SciAps to launch handheld LIBS instrument
Olympus expands NDT concern with Canadian acquisition
Lumense raises funds for sensor manufacturing
Repligen sells drug compound
Features
Bottom falls out of the M&A market in 2013
Growth slows for EU instrument sector
Financials
Life science firms grow despite funding squeeze
Affymetrix returns to the black after earnings fail to impress
Legal costs his Bio-Rad in Q4
PBC gain on Roche deal
New product and applied markets drive Danaher
Illumina ends its stellar year with a flourish
Qiagen meets targets for 2013
Cepheid gains as sales impress
Instrument firms soar in target-beating Q4
Thermo Fisher gains on outlook
MT beats as European market improves
Waters satisfies in a stronger Q4
Agilent shares dip on soft guidance
FEI ends the year with record sales
Bruker sails over targets in Q4
IDEX beats on earnings in Q4
Process firms optimistic as industrial sector recovers
Teledyne breaks the billion dollar barrier for instrument sales
Detection drops to loss on costs
HHT ups guidance on strong markets and weak yen
Newport sees final quarter pickup
Ametek looks to growth ahead
Danaher maintains growth
Margins lift Grace’s bottom line
Appointments